Telix Pharmaceuticals to Present at Jefferies Healthcare Conference

NEXT STORY
Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans
PREV STORY
Aptose Announces Closing of Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agios Presents Positive Results from Phase 2 Study of Mitapivat in Non-transfusion-dependent α- and β-Thalassemia at the European Hematology Association Virtual Congress

author_avatar
NASDAQ Market News

AB Science announces the first presentation of preclinical results for compound AB8939 in the 61st ASH Annual Meeting online program

author_avatar
NASDAQ Market News

Kiadis Pharma kondigt drie presentaties over K-NK-celtherapieplatform op ASCO 2020

author_avatar
NASDAQ Market News